Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.

Autor: Ramharter M; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel, Hamburg, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Djimde AA; Malaria Research and Training Center (MRTC), Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali., Borghini-Fuhrer I; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland., Miller R; Artemida Pharma, Stevenage, UK., Shin J; Shin Poong Pharm. Co. Ltd, Seoul, Korea., Aspinall A; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland., Richardson N; Magenta Communications Ltd, Abingdon, UK., Wibberg M; DATAMAP GmbH, Freiburg, Germany., Fleckenstein L; Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA., Arbe-Barnes S; Artemida Pharma, Stevenage, UK., Duparc S; Medicines for Malaria Venture, Route de Pré-Bois 20, 1215, Geneva 15, Switzerland. duparcs@mmv.org.

Publikováno v: Malaria journal [Malar J] 2024 Feb 28; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 28.

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.

Autor: Tan B; College of Pharmacy, University of Iowa, Iowa City, Iowa, United States of America., Opoku N; Onchocerciasis Chemotherapy Research Centre, Hohoe, Ghana.; University of Health and Allied Sciences (UHAS), Ho, Ghana., Attah SK; Onchocerciasis Chemotherapy Research Centre, Hohoe, Ghana., Awadzi K; Onchocerciasis Chemotherapy Research Centre, Hohoe, Ghana., Kuesel AC; UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (WHO/TDR), World Health Organization, Geneva, Switzerland., Lazdins-Helds J; UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (WHO/TDR), World Health Organization, Geneva, Switzerland., Rayner C; Monash University, Victoria, Australia., Ryg-Cornejo V; Medicines Development for Global Health, Southbank, Victoria, Australia., Sullivan M; Medicines Development for Global Health, Southbank, Victoria, Australia.; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Fleckenstein L; College of Pharmacy, University of Iowa, Iowa City, Iowa, United States of America.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Mar 25; Vol. 16 (3), pp. e0010005. Date of Electronic Publication: 2022 Mar 25 (Print Publication: 2022).

Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Autor: Bogoch II; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa isaac.bogoch@uhn.ca., Khan K; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa., Abrams H; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa., Nott C; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa., Leung E; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa., Fleckenstein L; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa., Keystone JS; Division of General Internal Medicine, University Health Network, Toronto, Canada; Division of Infectious Diseases, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada; Department of Pharmacy, St. Michael's Hospital, Toronto, Canada; Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa.

Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2015 Jul; Vol. 93 (1), pp. 94-6. Date of Electronic Publication: 2015 Apr 27.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Autor: Ouédraogo AL; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Bastiaens GJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Tiono AB; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Guelbéogo WM; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Kobylinski KC; Entomology Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland Entomology Department, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand., Ouédraogo A; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Barry A; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Bougouma EC; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Nebie I; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Ouattara MS; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Lanke KH; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Fleckenstein L; College of Pharmacy, The University of Iowa, Iowa City., Sauerwein RW; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Slater HC; MRC Centre for Outbreak Analysis and Modelling, Infectious Disease Epidemiology, Imperial College London., Churcher TS; MRC Centre for Outbreak Analysis and Modelling, Infectious Disease Epidemiology, Imperial College London., Sirima SB; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Drakeley C; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, United Kingdom., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, United Kingdom.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2015 Feb 01; Vol. 60 (3), pp. 357-65. Date of Electronic Publication: 2014 Nov 19.

Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.

Autor: Schmidt MS; College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA., King CL; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA., Thomsen EK; Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Siba PM; Papua New Guinea Institute for Medical Research, Papua New Guinea., Sanuku N; Papua New Guinea Institute for Medical Research, Papua New Guinea., Fleckenstein L; College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA. Electronic address: l-fleckenstein@uiowa.edu.

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2014 Sep; Vol. 98, pp. 307-10. Date of Electronic Publication: 2014 May 22.